Antheia's 2022 in Review: A Year of Value
Dear colleagues, friends, and followers: This year has been ripe with growth, major achievements, and opportunities to showcase who and...
top of page
Search
Antheia
- Nov 20, 2022
Antheia CEO on How Biomanufacturing can De-Risk Pharmaceutical Production
In a recent Q&A with European Pharmaceutical Manufacturer Antheia CEO and co-founder Dr. Christina Smolke discussed how latency...
![Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]](https://static.wixstatic.com/media/b9c8d9_033a0c34250244f7bfb280d4acafdb1e~mv2.png/v1/fill/w_439,h_330,fp_0.50_0.50,q_95,enc_auto/b9c8d9_033a0c34250244f7bfb280d4acafdb1e~mv2.png)
Antheia
- Sep 28, 2022
Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]
Antheia CEO and co-founder Christina Smolke shared how synthetic biology can help solve pressing pharma challenges during the 2022 CPHI...
Antheia
- Aug 25, 2022
Demystifying Synthetic Biology Part V: The Product is Key in Downstream Processing
Dive into DSP in the final edition of our Demystifying SynBio series. If you’re just joining us, be sure to catch up on parts I, II, III,...
Antheia
- Aug 16, 2022
Introducing Guerin Kob, Antheia’s VP of Supply Chain
With a pilot plant on the horizon and a pipeline filled with promise, Antheia is poised to soon establish a fermentation-based supply...
Antheia
- Jul 18, 2022
Demystifying Synthetic Biology IV: Fermentation Bioprocess Development
Learn more about synbio and the tools and technologies advancing this field in Part I, Part II, and Part III of this blog series....
Antheia
- Jun 22, 2022
Antheia Announces New Financing and Plans to Construct Pilot Plant Facility for Biomanufacturing
Financing will support new plant at Antheia headquarters to accelerate scale up for company’s pipeline of plant-based compounds; plant...
Antheia
- Jun 12, 2022
Demystifying Synthetic Biology III: The 21st Century Technologies Advancing Synthetic Biology
Just joining us? Check out Part I and Part II of the series. Synthetic biology is often touted as a software-driven and...
Antheia
- Jun 5, 2022
Introducing CPO Heidi Pucel
Growth and change can be challenging within dynamic, evolving startups, but it’s easier to navigate when you are tuned in to how people...
Antheia
- Apr 13, 2022
Demystifying Synthetic Biology II: Molecular Biology Advancements Enabling Synthetic Biology
Just joining us? Start with part one of our demystifying synthetic biology series. Synthetic biology seems like a brand-new, precision...
Antheia
- Feb 22, 2022
Antheia Appoints Heidi Pucel as Chief People Officer
MENLO PARK, Calif., Feb. 22, 2022 /PRNewswire/ -- Antheia, a synthetic biology company enabling next-generation plant-inspired medicines,...
Antheia
- Feb 9, 2022
Demystifying Synthetic Biology: Building with the power of biology
Technology today is defined by superlatives: we have the fastest cars, the best medicine, and the most advanced communication tools ever...
Antheia
- Jan 5, 2022
Inspirational Women in STEM and Tech: Dr. Christina Smolke of Antheia On The 5 Leadership Lessons...
Inspirational Women in STEM and Tech: Dr. Christina Smolke of Antheia On The 5 Leadership Lessons She Learned From Her Experience As a...
Antheia
- Jan 5, 2022
Seven Biopharma Trends to Watch in 2022
Synthetic biology attracted $8.9 billion in venture funding during the first half of 2021, according to synbio stakeholder group...
Antheia
- Dec 10, 2021
Introducing Zack McGahey, Antheia’s COO
Antheia is at a critical point in scaling our production technology. Just as we bring together exceptional science and technologies to...
Antheia
- Nov 23, 2021
Can Synthetic Biology Save Us? This Scientist Thinks So.
Drew Endy is squarely focused on the potential of redesigning organisms for useful purposes. He also acknowledges significant challenges....
Antheia
- Nov 19, 2021
BioSpace Movers & Shakers, Nov. 19
Antheia – Zack McGahey was named COO and will be responsible for all operations functions as the company scales and commercializes its...
Antheia
- Nov 18, 2021
Antheia Appoints Zack McGahey as Chief Operating Officer
MENLO PARK, Calif., Nov. 18, 2021 /PRNewswire/ -- Antheia, a synthetic biology company enabling next-generation plant-inspired medicines,...
Antheia
- Oct 12, 2021
Making Drugs From Yeast
Antheia CEO Christina Smolke brews up new pharmaceuticals. Watch the video interview at nbcbayarea.com
Christina Smolke
- Oct 12, 2021
Join the Movement to Build a Century-Defining Technology
Synthetic biology isn’t a household name - yet. But it will be soon, because it’s a thriving, innovative field that’s solving some of...
Antheia Newsroom
bottom of page